溶解性 | DMSO |
存贮条件 | 储存温度-20°C |
生化机理 | Radezolid (INN, codenamed RX-1741) is a novel oxazolidinone antibiotic being developed by Rib-X Pharmaceuticals, Inc. for the treatment of serious multi-drug–resistant infections. Radezolid has completed two phase-II clinical trials. One of these clinical trials was for uncomplicated skin and skin-structure infections (uSSSI) and the other clinical trial was for community acquired pneumonia (CAP). From Wikipedia |
别名 | ; |
Radezolid,噁唑烷酮类抗生素
Radezolid (订货以英文为准)
编号:R126228
CAS号:869884-78-6
分子式:C22H23FN6O3
分子量:438.45
产品名称 | Radezolid |
中文名称 | Radezolid,噁唑烷酮类抗生素 |
CAS号 | 869884-78-6 |
分子式(M.F.) | C22H23FN6O3 |
分子量(M.W.) | 438.45 |
储存条件 | -20°C储存 |
标识符号 | https://www.aladdin-e.com/images/ghs/ghs06.jpg |
信号词 | Danger |
危害声明 | H300 |
警示性声明 | P264-P301 + P310 |
RTECS | XJ9095000 |
WGK德国 | 3 |
搜索质检报告(COA)
搜索MSDS
相关产品